potent
immunosuppress
drug
cyclosporin
csa
known
inhibit
human
cell
infect
pathogen
protozoan
parasit
leishmania
major
vitro
vivo
propos
mechan
action
involv
csa
bind
leishmania
majorexpress
cyclophilin
subsequ
downregul
signal
event
necessari
establish
product
infect
recent
identifi
ubiquit
express
membran
protein
signal
receptor
extracellular
cyclophilin
mammalian
cell
demonstr
enzymat
activ
leishmania
cyclophilin
unlik
human
homologu
interact
cell
surfac
target
cell
facilit
neither
leishmania
bind
infect
primari
structur
biochem
analys
reveal
parasit
cyclophilin
defect
heparan
bind
event
requir
signal
interact
human
cyclophilin
heparanbind
motif
reconstitut
leishmania
cyclophilin
regain
signal
activ
result
underscor
critic
role
cyclophilinheparan
interact
signal
event
argu
role
leishmania
cyclophilin
parasit
bind
target
cell
leishmania
protozoan
parasit
caus
wide
spectrum
diseas
collect
known
leishmaniasi
transmiss
vertebr
host
initi
flagel
metacycl
promastigot
via
bite
infect
femal
sandfli
vector
within
mammalian
host
parasit
enter
macrophag
transform
replic
amastigot
stage
depend
speci
initi
infect
immunolog
statu
host
diseas
form
rang
simpl
cutan
mucocutan
diffus
cutan
viscer
leishmania
major
wellstudi
old
world
speci
caus
cutan
diseas
human
mice
farrel
cyclosporin
csa
report
inhibit
infect
human
pathogen
protozoan
parasit
vitro
vivo
chappel
wastl
meissner
et
al
bua
et
al
sinc
main
target
csa
cyclophilin
sensit
protozoan
infect
csa
suggest
import
role
cyclophilin
may
play
protozoan
life
cycl
cyclophilin
larg
famili
protein
possess
peptidylprolyl
cistran
isomeras
activ
believ
play
import
role
cell
physiolog
chaperon
barik
regul
protein
fold
kofron
et
al
addit
intracellular
function
cyclophilin
releas
cell
respons
variou
stimuli
inflammatori
mediat
includ
reactiv
oxygen
speci
ro
lipopolysaccharid
lp
sherri
et
al
jin
et
al
suzuki
et
al
extracellular
cyclophilin
exert
potent
chemotact
activ
toward
mani
type
immun
cell
may
contribut
pathogenesi
sever
inflammatori
diseas
rheumatoid
arthriti
acut
lung
injuri
allerg
asthma
arora
et
al
kim
et
al
gwinn
et
al
review
yurchenko
et
al
ubiquit
express
membran
protein
shown
play
critic
role
signal
respons
mammalian
cell
extracellular
cyclophilin
contribut
varieti
cyclophilinmedi
physiolog
patholog
activ
review
yurchenko
et
al
cyclophilin
produc
mani
protozoan
parasit
interestingli
sever
trypanosomatid
eg
trypanosoma
cruzi
secret
cyclophilinlik
protein
host
cell
infect
antibodi
rais
cruzi
isomeras
greatli
reduc
parasit
infect
moro
et
al
result
suggest
parasit
might
secret
cyclophilin
initi
signal
event
target
cell
thu
creat
optim
environ
entri
replic
three
isoform
leishmania
major
cyclophilin
lmcyp
molecular
mass
kda
identifi
hoerauf
et
al
rascher
et
al
kda
protein
major
isoform
lmcyp
two
isoform
may
result
posttransl
modif
degrad
cyclophilin
rascher
et
al
role
parasit
life
cycl
remain
uncharacter
enzymat
peptidylprolyl
cistran
isomeras
activ
lmcyp
isoform
greatli
reduc
csa
howev
unlik
human
cyclophilin
complex
csa
bind
caregul
phosphatas
calcineurin
rascher
et
al
surprisingli
pretreat
parasit
csa
diminish
level
macrophag
infect
hoerauf
et
al
structur
studi
cyclophilin
anoth
speci
leishmania
leishmania
donovani
reveal
complet
structur
conserv
cyclosporinbind
site
respect
homolog
human
protein
deviat
primarili
loop
region
venugop
et
al
given
interact
human
cyclophilin
sensit
csa
involv
enzymat
activ
site
cyclophilin
yurchenko
et
al
hypothes
secret
may
facilit
parasit
infect
induc
signal
target
macrophag
investig
whether
interact
leishmaniasecret
facilit
infect
parasit
demonstr
unlik
human
cyclophilin
interact
human
surfac
target
cell
facilit
neither
leishmania
bind
infect
compar
analysi
human
cypa
reveal
leishmania
protein
defect
heparan
bind
requir
cypainiti
signal
transduct
restor
heparan
bind
capac
mutagenesi
also
restor
signal
activ
promastigot
l
major
kindli
provid
dr
mcmahonpratt
yale
school
public
health
cultur
grace
medium
invitrogen
carlsbad
ca
supplement
heatinactiv
fc
lgml
gentamicin
invitrogen
describ
previous
scott
et
al
halfconflu
cultur
chines
hamster
ovari
cho
cell
cellswel
plate
expos
parasit
ratio
h
serumfre
medium
invitrogen
previous
describ
guinet
et
al
cell
wash
three
time
pb
buffer
kept
growth
medium
supplement
heatinactiv
fc
level
infect
monitor
h
pi
light
microscopi
wildtyp
heparandefici
cell
line
purchas
atcc
chopcdna
cell
line
describ
previous
yurchenko
et
al
mitogenactiv
protein
kinas
mapk
antibodi
cell
signal
technolog
danver
mab
block
cyclophilininduc
chemotaxi
signal
pushkarski
et
al
yurchenko
et
al
ancel
bayport
mn
horseradish
peroxidas
hrp
label
antiglutathionestransferas
gst
mab
purchas
ge
healthcar
piscataway
nj
heparitinas
iii
cleav
heparin
anacetylglucosaminideliduron
acid
linkag
purchas
seikagaku
america
falmouth
leishmania
major
promastigot
label
tritiat
uracyl
ge
healthcar
previous
describ
mosser
edelson
parasit
incub
cell
variou
parasitetocel
ratio
h
wash
three
time
pb
retain
radioact
measur
multipurpos
scintil
counter
beckman
coulter
fullerton
ca
escherichia
coli
produc
gst
gsttag
cypa
lyse
pet
lysi
buffer
mm
trishcl
ph
mm
dithiothreitol
dtt
mm
edta
triton
mm
phenylmethanesulphonylfluorid
pmsf
incub
heparan
agaros
pierc
biotechnolog
rockford
il
overnight
extens
wash
pb
heparanbound
protein
elut
laemmli
sd
sampl
buffer
laemmli
separ
sd
page
visual
antigst
antibodi
dna
encod
amino
acidlong
l
major
cyclophilin
amino
acid
rascher
et
al
clone
emd
bioscienc
san
diego
ca
new
england
biolab
ipswich
ge
healthcar
vector
purifi
accord
manufactur
protocol
clone
detail
primer
use
avail
upon
request
three
construct
yield
significantli
less
protein
similar
construct
express
human
cypa
highest
level
express
achiev
express
plasmid
sitedirect
mutagenesi
encod
plasmid
perform
use
quikchang
ii
sitedirect
mutagenesi
kit
stratagen
la
jolla
ca
escherichia
coliproduc
hisor
gsttag
protein
purifi
clear
lysat
affin
chromatographi
ninta
agaros
qiagen
valencia
ca
glutathionesepharos
ge
healthcar
respect
accord
manufactur
protocol
tag
cleav
cypa
use
biotinyl
thrombin
remov
streptavidin
agaros
emd
bioscienc
accord
manufactur
protocol
serumstarv
cho
cell
stabli
transfect
pcdna
construct
yurchenko
et
al
treat
variou
concentr
cell
lysat
separ
sdspage
analyz
western
blot
use
map
kinas
antibodi
new
englandbiolab
peptidylprolyl
cistran
isomeras
assay
perform
mm
acid
hepe
buffer
ph
use
substrat
peptid
sucaapfpna
alapro
bond
equilibrium
ci
tran
conform
sherri
et
al
pnitroanilin
chromophor
releas
alltran
peptid
monitor
nm
rate
constant
determin
previous
describ
sherri
et
al
previou
studi
shown
via
interact
virusassoci
cyclophilin
facilit
entri
host
cell
pushkarski
et
al
coronaviru
chen
et
al
hypothes
leishmaniaproduc
might
function
similar
manner
interact
facilit
infect
parasit
quantit
analysi
role
leishmania
infect
employ
cho
cell
line
stabli
transfect
human
empti
vector
chopcdna
neg
control
cho
cell
propos
ideal
vitro
model
studi
hostparasit
interact
guinet
et
al
rel
easi
cultur
infect
cell
line
character
previous
yurchenko
et
al
fig
show
chopcdna
cell
line
equal
infect
l
major
although
small
differ
infect
rate
two
cell
line
notic
statist
signific
remain
possibl
infect
l
major
facilit
hamster
present
cho
cell
exclud
possibl
use
antibodi
clone
previous
shown
block
cypainduc
signal
event
cell
yurchenko
et
al
experi
detect
differ
parasit
infect
presenc
absenc
antibodi
fig
nevertheless
consist
previous
publish
observ
meissner
et
al
presenc
csa
infect
reduc
rate
infect
cell
approxim
nontreat
cell
approxim
presenc
lgml
csa
fig
exclud
possibl
contribut
parasit
bind
cell
surfac
even
though
effect
dampen
due
highlevel
infect
cho
cell
compar
l
major
bind
chopcdna
cell
leishmania
major
promastigot
radiolabel
incub
host
cell
line
ratio
h
extens
wash
cellassoci
radioact
measur
similar
result
obtain
three
set
infect
condit
exampl
analysi
ratio
present
fig
show
chopcdna
cell
bind
leishmania
similar
effici
moreov
pretreat
cell
block
antibodi
appreci
chang
level
parasit
bind
therefor
essenti
leishmania
infect
proteoglycan
cell
surfac
shown
facilit
adhes
leishmania
amastigot
macrophag
vitro
love
et
al
propos
parasit
express
surfac
secret
highaffin
heparanbind
protein
interact
heparan
sulfat
proteoglycan
mammalian
cell
butcher
et
al
interact
may
repres
import
first
step
celltocel
transmiss
leishmania
amastigot
sinc
cypa
bind
heparan
sulphat
saphir
et
al
hypothes
heparan
rather
may
function
receptor
facilit
infect
parasit
first
test
whether
heparansulf
import
promastigot
bind
addit
chopcdna
cell
line
use
two
cell
line
lack
heparansulf
remov
heparan
also
pretreat
cell
heparitinas
iii
cleav
heparan
anacetylglucosaminideliduron
acid
yurchenko
et
al
shown
fig
absenc
proteoglycan
bind
l
major
promastigot
greatli
diminish
indic
similar
amastigot
bind
heparansulf
cell
surfac
facilit
infect
promastigot
note
interact
might
repres
import
initi
step
leishmania
infect
presenc
human
appreci
chang
l
major
bind
taken
togeth
result
present
fig
indic
l
major
bind
infect
depend
facilit
heparan
sulphat
next
address
question
whether
similar
human
homologu
stimul
downstream
signal
transduct
event
previous
demonstr
essenti
compon
cyclophilininiti
signal
cascad
culmin
extracellular
signalregul
kinas
erk
activ
yurchenko
et
al
compar
human
cypa
abil
induc
erk
activ
cypa
express
e
coli
purifi
close
homogen
fig
twostep
affin
chromatographi
see
section
protein
activ
peptidylprolyl
cistran
isomer
assay
although
note
lower
activ
lmcyp
tabl
fig
show
activ
erk
kinas
lane
chopcdna
lane
cell
wherea
concentr
human
cypa
stimul
erk
phosphoryl
cell
line
lane
chopcdna
cell
lane
also
note
similar
human
cypa
cypb
yurchenko
et
al
high
concentr
nm
initi
signal
transduct
respons
data
shown
previous
demonstr
essenti
role
heparan
sulfat
proteoglycan
cypainduc
signal
event
yurchenko
et
al
reason
inabl
induc
signal
could
due
defect
interact
heparan
sulfat
bind
heparan
reduc
compar
cypa
fig
estim
heparan
affin
approxim
cypa
protein
understand
molecular
mechan
respons
observ
differ
human
cypa
compar
primari
structur
protein
fig
previous
shown
halfconflu
cultur
chopcdna
triangl
circl
cell
expos
parasit
h
serumfre
medium
level
infect
monitor
indic
time
pi
light
microscopi
result
mean
sd
three
independ
experi
present
percentag
infect
cell
differ
infect
rate
chopcdna
cell
line
statist
signific
b
cell
infect
panel
presenc
lgml
csa
squar
lgml
block
antibodi
circl
ad
togeth
parasit
noth
ad
control
sampl
triangl
result
mean
sd
three
independ
experi
c
leishmania
major
promastigot
radiolabel
use
assess
bind
indic
cho
cell
line
denot
bind
cell
pretreat
lgml
antibodi
cell
pretreat
lgml
isotyp
control
antibodi
heparandefici
cell
transfect
heparandefici
cell
transfect
iii
denot
cell
pretreat
heparitinas
iii
remov
heparan
result
mean
sd
three
independ
experi
mutat
result
almost
complet
loss
rotamas
activ
mutant
retain
rotamas
activ
wildtyp
protein
zydowski
et
al
affect
rotamas
activ
essenti
cypcsa
interact
liu
et
al
amino
acid
form
cyp
activ
site
number
accord
human
protein
conserv
fig
shade
consist
analysi
isomeras
activ
slightli
lower
cypa
tabl
contrast
two
four
basic
amino
acid
determin
heparan
bind
activ
human
cypa
yurchenko
et
al
conserv
lysin
posit
correspond
cypa
substitut
threonin
prolin
respect
fig
bold
verifi
lysin
threonin
lysin
prolin
substitut
posit
critic
observ
differ
human
leishmania
cyclophilin
chang
residu
back
lysin
mutant
regain
abil
bind
heparan
fig
importantli
becam
capabl
initi
signal
induc
erk
phosphoryl
fig
lane
chopcdna
cell
fig
lane
introduc
mutat
affect
isomeras
activ
tabl
human
cypa
cypb
two
type
bind
site
identifi
deni
et
al
yurchenko
et
al
type
site
specif
function
receptor
k
cat
k
valu
calcul
subtract
background
isomer
fit
data
iter
pseudo
firstord
kinet
equat
rascher
et
al
mediat
intern
signal
bound
cyclophilin
type
ii
site
repres
sulfat
glycosaminoglycan
recent
demonstr
one
heparan
sulfat
proteoglycan
core
protein
physic
associ
necessari
signal
chemotact
activ
cypb
pakula
et
al
propos
cypa
bind
first
heparan
cell
surfac
order
present
type
receptor
effici
interact
yurchenko
et
al
similar
function
heparan
describ
mani
chemoattract
agent
fibroblast
growth
factor
fgf
chemokin
regul
activ
normal
cell
express
secret
rant
schonherr
hausser
appear
due
substitut
unabl
bind
heparan
effici
human
counterpart
thu
inabl
induc
signal
via
structur
peculiar
also
argu
role
heparandepend
bind
l
major
target
cell
result
identifi
import
differ
human
counterpart
cypa
contrast
cypa
interact
induc
signal
sinc
cyclophilin
mediat
inflammatori
respons
via
interact
yurchenko
et
al
featur
may
help
leishmania
avoid
chemoattract
immun
cell
site
infect
given
high
conserv
rotamas
site
role
parasit
infect
like
concern
chaperon
function
seem
contribut
directli
parasit
interact
target
cell
remain
determin
whether
secret
result
indic
extracellular
activ
unlik
factor
diseas
pathogenesi
